Is an Insulin-like Growth Factor-1 (IGF-1) level of 80 considered low for a 60-year-old female with an Adrenocorticotropic Hormone (ACTH) level of 91, cortisol level of 20.5, a normal Dexamethasone (Dex) suppression test, and normal prolactin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of IGF-1 Level of 80 in a 60-Year-Old Female

An IGF-1 level of 80 in a 60-year-old female is likely below the age-adjusted reference range and warrants further evaluation for potential growth hormone deficiency, especially in the context of normal ACTH, cortisol, and prolactin levels.

Interpretation of the Laboratory Values

IGF-1 Assessment

  • IGF-1 levels naturally decline with age, but a value of 80 in a 60-year-old female is likely at the lower end or below the age-adjusted normal range 1
  • Low IGF-1 requires comparison to age-specific and sex-specific reference ranges for proper interpretation 2
  • IGF-1 is a reliable marker for growth hormone status, with low levels suggesting potential growth hormone deficiency 3

Context of Other Laboratory Values

  • Normal ACTH (91) and cortisol (20.5) with normal dexamethasone suppression test suggest intact hypothalamic-pituitary-adrenal axis function
  • Normal prolactin levels rule out prolactinoma, which could otherwise affect pituitary function 2
  • These findings together suggest a selective abnormality in the GH-IGF-1 axis rather than global pituitary dysfunction

Potential Causes of Low IGF-1

Growth Hormone Deficiency

  • Primary consideration in patients with low IGF-1 levels, especially in the context of normal other pituitary hormones 4
  • In adults over 40 years, IGF-1 values exceeding 15 nmol/l virtually exclude growth hormone deficiency, but values below this threshold warrant further investigation 3

Non-Functioning Pituitary Adenoma

  • May cause local compression of normal pituitary tissue, leading to decreased GH production while other hormones remain normal 1, 5
  • Can present with isolated GH deficiency before affecting other pituitary hormones

Confounding Factors

  • Several conditions can cause falsely low IGF-1 values:
    • Severe hypothyroidism (should be ruled out)
    • Malnutrition or low energy availability 2
    • Severe infection
    • Oral estrogen therapy 2, 1
    • Liver disease 6

Recommended Evaluation

Initial Assessment

  1. Confirm IGF-1 level with repeat measurement using the same assay
  2. Complete pituitary hormone assessment:
    • TSH and free T4 to rule out hypothyroidism
    • FSH and LH to assess gonadal axis
    • Comprehensive metabolic panel to assess liver and kidney function

Specialized Testing

  1. GH stimulation testing (insulin tolerance test or GHRH-arginine test) to confirm GH deficiency 1
  2. Pituitary MRI to evaluate for potential microadenoma or other structural abnormalities

Clinical Implications

Health Consequences of Low IGF-1

  • Decreased muscle mass and strength
  • Increased adiposity
  • Reduced bone mineral density (particularly concerning in a 60-year-old female) 2
  • Impaired quality of life
  • Altered lipid metabolism 1

Potential Pitfalls

  • Misinterpreting IGF-1 levels without proper age-adjusted reference ranges
  • Overlooking confounding factors that can lower IGF-1 independently of GH status
  • Focusing only on one hormone axis without comprehensive pituitary evaluation
  • Assuming normal ACTH/cortisol excludes all pituitary pathology 1

Management Considerations

If GH deficiency is confirmed:

  • Consider GH replacement therapy based on clinical presentation and severity of deficiency
  • Regular monitoring of IGF-1 levels to guide therapy
  • Bone density assessment given increased osteoporosis risk
  • Regular follow-up imaging if structural pituitary abnormality is identified

This patient's laboratory profile suggests a potential isolated GH deficiency that requires further specialized endocrinological evaluation to confirm the diagnosis and determine appropriate management.

References

Guideline

Evaluation and Management of Pituitary Adenomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Plasma IGF-I is a useful marker of growth hormone deficiency in adults.

Journal of endocrinological investigation, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.